Obsessive compulsive disorder comorbidity in DBA.

Area of Science:

• Hematology
• Neuropsychiatry
• Pediatrics

Background:

• Diamond-Blackfan Anemia (DBA) is a congenital disorder affecting red blood cell production.
• DBA is typically associated with developmental delays, but psychiatric comorbidities are rarely documented.
• Obsessive-compulsive disorder (OCD) is a distinct psychiatric condition requiring specific management.

Purpose of the Study:

• To report a case of Diamond-Blackfan Anemia (DBA) with a comorbid diagnosis of obsessive-compulsive disorder (OCD).
• To highlight the clinical, therapeutic, and pathophysiological implications of this rare comorbidity.
• To emphasize the need for adapted screening tools in DBA patients with potential mental disorders.

Main Methods:

• Case report of a DBA patient with undiagnosed OCD.
• Pharmacological treatment with sertraline and valproic acid.
• Clinical observation and assessment of treatment response.

Main Results:

• Successful management of OCD symptoms in a DBA patient using sertraline (200 mg/day) and valproic acid (600 mg/day).
• Demonstration that comorbid OCD can be effectively treated without exacerbating DBA symptoms.
• Identification of challenges in differentiating OCD from existing learning disabilities in DBA patients.

Conclusions:

• DBA patients may present with undiagnosed psychiatric comorbidities such as OCD.
• Integrated screening and treatment approaches are essential for managing comorbid conditions in DBA.
• Further research is needed to understand the pathophysiological links and optimize therapeutic strategies for comorbid DBA and OCD.